← Back to Search

Mobile App for Smokers

Waitlist Available
Led By Paul Cinciripini
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Current smokers (those who smoke at least 5 cigarettes a day; confirmed with carbon monoxide (CO) levels equal or above 7 parts per million ) newly enrolled in the Tobacco Treatment Program at MDACC (Aim 2 )
Current smokers seeking care at the Tobacco Treatment Program at MD Anderson and at Houston area community services who have smoked at least 100 cigarettes in lifetime
Must not have
Be younger than 18 years old
Screening 3 weeks
Treatment Varies
Follow Upup to 5 weeks
Awards & highlights
No Placebo-Only Group

Study Summary

This trial looks at whether a mobile app can help people quit smoking. The app is based on a computer program that has helped people quit smoking in the past.

Eligible Conditions
  • Smokers
  • Cigarette Smokers
  • Everyday Smoker
  • Cancer

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You have smoked at least 100 cigarettes in your lifetime and are currently seeking care at the Tobacco Treatment Program at MD Anderson or Houston area community services.
Both males and females can participate (for Aim 2).
You need to have either an iPhone or an Android smartphone (for Aim 2).
You are willing to download and use the Quitting Schedule app as part of the study.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adaptation of the programmatic infrastructure of WebCASSI (Computer Assisted Stop Smoking Intervention for the World Wide Web) into a more-portable table and smartphone application (app) that will be available both in English and Spanish
Pre-testing of the app

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Prevention (smoking reduction, Quitting Schedule mobile app)Experimental Treatment4 Interventions
AIM I: Participants follow an individually tailored gradual reduction of smoking schedule for 5 weeks while MDACC eHealth adapts WebCASSI into a smartphone app: Quitting Schedule. AIM II: Participants pre-test the Quitting Schedule mobile smartphone app for 5 weeks.
First Studied
Drug Approval Stage
How many patients have taken this drug
Smoking Cessation Intervention

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,914 Previous Clinical Trials
1,773,733 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,486 Previous Clinical Trials
41,265,918 Total Patients Enrolled
2 Trials studying Smokers
1,250 Patients Enrolled for Smokers
Paul CinciripiniPrincipal InvestigatorM.D. Anderson Cancer Center
3 Previous Clinical Trials
3,021 Total Patients Enrolled

Media Library

Quitting Schedule Mobile Smartphone Application Clinical Trial Eligibility Overview. Trial Name: NCT03668769 — N/A
Smokers Research Study Groups: Prevention (smoking reduction, Quitting Schedule mobile app)
Smokers Clinical Trial 2023: Quitting Schedule Mobile Smartphone Application Highlights & Side Effects. Trial Name: NCT03668769 — N/A
Quitting Schedule Mobile Smartphone Application 2023 Treatment Timeline for Medical Study. Trial Name: NCT03668769 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research experiment presently enrolling participants?

"Per the latest update on clinicaltrials.gov, this medical research is no longer searching for volunteers; originally posted in March 2017 and last edited June 2022. Despite its closure, there are 2392 other trials recruiting participants right now."

Answered by AI
~0 spots leftby Dec 2023